Chronic Pain Clinical Trial
Official title:
Feasibility and Acceptability of Interoception-Based Yoga for Chronic Pain
The purpose of this research is to examine the feasibility and acceptability of an interoception-based yoga program for chronic pain. Interoception involves your ability to feel sensations in your body (such as your heartbeat or muscle tension) as well as how you think about and interpret those sensations. Interoception may be an important component of chronic pain and the research team is studying whether yoga can change how you feel, think about, and interpret sensations in your body.
Status | Recruiting |
Enrollment | 32 |
Est. completion date | December 30, 2024 |
Est. primary completion date | December 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 64 Years |
Eligibility | Inclusion Criteria: - Self-reported chronic pain lasting = 3 months (such as widespread musculoskeletal pain, fibromyalgia, migraine etc.) - In the past week, has pain interfered with your day-to-day activities? Yes - Self-reported ambulatory ability without an assistive device - Self-reported ability to get on and off the floor without assistance. - No ongoing mind-body practice (<1x/week over the past 6 months). - Physical Activity Readiness Questionnaire Screen Pass or Physician Consent - English-speaking - Able and willing to provide consent - No plans to move or travel outside the area in the next 2 months Exclusion Criteria: - Ages <18 or = 65 at time of screening - Pain lasting < 3 months - In the past week, has pain interfered with your day-to-day activities? No - Use of any assistive device (e.g. cane, walker, wheelchair). - Inability to get on and off the floor without assistance. - A consistent ongoing mind-body practice (mindfulness, yoga, meditation, tai chi, qigong), at least 1x/week over the past 6 months - Physical Activity Readiness Questionnaire Screen Fail or non-consent of physician - Non-English speaking - Non-consent - Plans to move or significant travel outside the area in the next 2 months - Known pregnancy - Recent surgery or acute bone, joint or nerve injury (within the past 6 months) - Severe or progressive neurological conditions such as Parkinson's disease, dementia, multiple sclerosis, or acquired brain injury - Separate pain-related diagnoses: cancer-related pain, complex regional pain syndrome, postural orthostatic tachycardia syndrome, functional neurological/ movement disorders - Active or planned worker's compensation or personal injury claim - Concurrent participation in another interventional study (e.g. physical activity, mind-body or drug trials) |
Country | Name | City | State |
---|---|---|---|
United States | University of Illinois Urbana-Champaign | Urbana | Illinois |
Lead Sponsor | Collaborator |
---|---|
University of Illinois at Urbana-Champaign |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Interoceptive Accuracy | Heartbeat Tracking Task | Primary endpoint: 6 weeks | |
Other | Mindfulness | Five Facet Mindfulness Questionnaire (FFMQ), planned covariate for interoceptive sensibility | Primary endpoint: 6 weeks | |
Other | PROMIS Pain Intensity | Short Form 3a, planned covariate for pain interference. | Primary endpoint: 6 weeks | |
Other | Quality of Life | 36-Item Short Form Health Survey (SF-36) | Primary endpoint: 6 weeks | |
Other | Spiritual Wellbeing | Functional Assessment of Chronic Illness Therapy - Spiritual Wellbeing Scale (FACIT-Sp12) | Primary endpoint: 6 weeks | |
Other | Pain Impact | ASCQ Pain Impact Short Form | Primary endpoint: 6 weeks | |
Primary | Feasibility | Defined as achieving the target recruitment sample (N=25) in a 9-month period, 80% retention (N=20), 70% attendance rate, 70% home practice adherence and no serious adverse events. | Primary endpoint: 6 weeks | |
Primary | Acceptability | Defined as >5/7 on acceptability questionnaire (1 = unacceptable, 7 = very acceptable) | Primary endpoint: 6 weeks | |
Secondary | Interoceptive Sensibility | Multidimensional Assessment of Interoceptive Awareness, Version 2 (MAIA-2). Will take the mean of 5 MAIA-2 Subscales: attention regulation, emotional awareness, self-regulation, body listening, and trusting as the primary measure of preliminary efficacy. Planned post-hoc analyses will evaluate differential changes in all 8 subscales. | Primary endpoint: 6 weeks | |
Secondary | PROMIS Pain Interference | Short Form 8a | Primary endpoint: 6 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|